Ascentage Pharma Group International American Depository Shares When Issued
Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation. It also develops APG-2575, an oral administered Bcl-2 selective inhibit… Read more
Ascentage Pharma Group International American Depository Shares When Issued (AAPGV) - Net Assets
Latest net assets as of : $- USD
Based on the latest financial reports, Ascentage Pharma Group International American Depository Shares When Issued (AAPGV) has net assets worth $- USD as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($-) and total liabilities ($-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
Ascentage Pharma Group International American Depository Shares When Issued - Net Assets Trend (None–None)
This chart illustrates how Ascentage Pharma Group International American Depository Shares When Issued's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Ascentage Pharma Group International American Depository Shares When Issued (None–None)
The table below shows the annual net assets of Ascentage Pharma Group International American Depository Shares When Issued from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to Ascentage Pharma Group International American Depository Shares When Issued's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
Ascentage Pharma Group International American Depository Shares When Issued Competitors by Market Cap
The table below lists competitors of Ascentage Pharma Group International American Depository Shares When Issued ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
PULSION Medical Systems SE
MU:PUS
|
$206.38K |
|
CARNIVAL - Dusseldorf Stock Exchang
DU:POH1
|
$206.42K |
|
Virios Therapeutics Llc
NASDAQ:VIRI
|
$206.50K |
|
Blackrock Municipal Target Term Closed Fund
NYSE:BTT
|
$206.75K |
|
BANK OF AFRICA
BC:BANK-OF-AFRICA
|
$206.25K |
|
Hub Cyber Security Ltd. Ordinary Shares
NASDAQ:HUBC
|
$206.20K |
|
Antiaging Quantum Living Inc.
PINK:AAQL
|
$206.17K |
|
TOBA Investments Equities
CO:TOIEQT
|
$206.10K |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Ascentage Pharma Group International American Depository Shares When Issued's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares Ascentage Pharma Group International American Depository Shares When Issued's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Ascentage Pharma Group International American Depository Shares When Issued utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares Ascentage Pharma Group International American Depository Shares When Issued's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Ascentage Pharma Group International American Depository Shares When Issued (AAPGV) | $- | N/A | N/A | $206.32K |
| Abcam plc (ABCZF) | $15.07 Million | 22.73% | 0.21x | $5.00 Billion |
| Able View Global Inc. Warrant (ABLVW) | $7.09 Million | -104.63% | 5.72x | $277.93K |
| Above Food Ingredients Inc. Warrants (ABVEW) | $199.86 Million | -2.89% | 0.00x | $6.71 Million |
| Adamas Trust, Inc. (ADAMG) | $1.41 Billion | -4.40% | 5.53x | $2.07 Billion |
| ADS-TEC ENERGY PLC Warrant (ADSEW) | $13.74 Million | 0.00% | 2.67x | $9.38 Million |
| Alliance Entertainment Holding Corporation Warrants (AENTW) | $52.92 Million | 10.13% | 4.23x | $2.29 Million |
| Forafric Global PLC Warrants (AFRIW) | $51.99 Million | -0.21% | 3.57x | $2.67 Million |
| Centurion Acquisition Corp. Warrant (ALFUW) | $1.03 Million | -345.23% | 6.23x | $4.81 Million |
| Alliance Trust PLC (ALITF) | $2.41 Billion | -5.83% | 0.11x | $119.23K |
| Alvotech Warrant (ALVOW) | $-412.77 Million | 0.00% | 0.00x | $35.01 Million |